ask="2.04"
ask_size="36700"
average_daily_volume="2145590"
bid="1.95"
bid_size="300"
book_value="1.37"
change="+0.08"
change_from_200_day_moving_average="-2.88"
change_from_50_day_moving_average="0.17"
change_from_52_week_high="-6.32"
change_From_52_week_low="0.70"
change_in_percent="+4.40%"
close="1.90"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.34"
ebitda="-82.29M"
eps_estimate_current_year="-0.39"
eps_estimate_next_quarter="-0.14"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="62709000"
high="1.93"
high_52_weeks="8.22"
last_trade_date="2/3/2017"
last_trade_price="1.90"
last_trade_size="100"
last_trade_time="4:00pm"
low="1.77"
low_52_weeks="1.20"
market_capitalization="140.93M"
moving_average_200_day="4.78"
moving_average_50_day="1.73"
name="Arrowhead Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="1.80"
open="1.84"
pe_ratio="N/A"
peg_ratio="-0.64"
percent_change_from_200_day_moving_average="-60.22%"
percent_change_from_50_day_moving_average="+9.79%"
percent_change_from_52_week_high="-76.89%"
percent_change_from_52_week_low="+58.33%"
previous_close="1.82"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.33"
price_per_sales="852.60"
revenue="158333.00"
shares_outstanding="74173000"
short_ratio="4.40"
stock_exchange="NMS"
symbol="ARWR"
volume="836970"
weeks_range_52="1.20 - 8.22"
